Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.10+0.10 (+2.50%)
Close on Nov 18, 2026Market cap $257.29MP/E –Yield 0.00%
Camp4 Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Camp4 Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $4.22M, up 40.2% year over year. For fiscal 2025 it was $3.50M, up 436.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.50M | +436.5% |
| FY2024 | Dec 31, 2024 | $652.00K | +86.3% |
| FY2023 | Dec 31, 2023 | $350.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.78M | +18.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.29M | +50.8% |
| Q4 FY2025 | Dec 31, 2025 | $348.00K | -46.6% |
| Q3 FY2025 | Sep 30, 2025 | $795.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $1.50M | – |
| Q1 FY2025 | Mar 31, 2025 | $858.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $652.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $350.00K | – |
See a number that looks wrong?